Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California. Show more

12750 HIGH BLUFF DRIVE, SAN DIEGO, CA, UNITED STATES, 92130, San Diego, CA, 92130, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

6.205B

52 Wk Range

$60.00 - $200.00

Previous Close

$154.79

Open

$157.14

Volume

105,520

Day Range

$154.54 - $158.42

Enterprise Value

5.894B

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

44.27%

Institutional Own.

23.59%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Tinlarebant (LBS-008) Details Stargardt disease	NDA Acceptance for review	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tinlarebant (LBS-008) Details Stargardt disease	NDA Acceptance for review	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tinlarebant (LBS-008) Details Geographic atrophy	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.